Bryan Johnson’s Biomarkörer: The Science och Limits of Biological Age

Niko Hems’ 13 augusti review examines Bryan Johnson’s biomarker program och its limits. Hems describes the protocol as an instrumented n=1 that measures blood markers, imaging, functional tests, och epigenetic clocks. He accepts that the volume of measurement can support tracking, but separates data collection från clinical meaning. The review identifies 3 main problems: no control group, confounding från changing diet, exercise, sleep, tillskott, och other therapies together, och reliance on surrogate endpoints. Hems argues that a lower epigenetic age or slower pace of aging is not proof of fewer heart attacks, less cancer, or longer life. He treats grip strength och VO2 max as closer till functional outcomes than biological-age scores, while still presenting them as risk markers rather than randomiserad evidens. The review recommends medical interpretation och baseline assessment instead of self-quantification alone. It is a named critical response, not a new trial och not an independent audit of Johnson’s raw records. The artikel was uppdaterad on 13 augusti 2026, which is the date used here. It does not test any Blueprint ingrediens, does not report a human RCT of the stack, och gives no basis for an evidens-grade upgrade. Its main value is methodological: it states plainly what the offentligt data cannot identify.

Johnson's Blueprint project has raised awareness for preventive health och the value of data.